Ticker > Company >

Mercury Laboratories share price

Mercury Laboratories Ltd.

BSE: 538964 SECTOR: Pharmaceuticals & Drugs  13.26 K   19   0

845.00
0 0
BSE: 29 Aug 04:01 PM

Price Summary

Today's High

₹ 845

Today's Low

₹ 845

52 Week High

₹ 1190

52 Week Low

₹ 736

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

101.4 Cr.

Enterprise Value

103.3 Cr.

No. of Shares

0.12 Cr.

P/E

26.9

P/B

1.86

Face Value

₹ 10

Div. Yield

0.41 %

Book Value (TTM)

₹  454.47

CASH

2.19 Cr.

DEBT

4.09 Cr.

Promoter Holding

73.66 %

EPS (TTM)

₹  31.42

Sales Growth

-0.61%

ROE

6.02 %

ROCE

9.14%

Profit Growth

-44.38 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-0.61%
3 Year9.04%
5 Year5.57%

Profit Growth

1 Year-44.38%
3 Year-4.07%
5 Year-0.52%

ROE%

1 Year6.02%
3 Year10.24%
5 Year11.09%

ROCE %

1 Year9.14%
3 Year12.98%
5 Year14.35%

Debt/Equity

0.0764

Price to Cash Flow

25.34

Interest Cover Ratio

9.5114

CFO/PAT (5 Yr. Avg.)

1.20638132429448

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 73.66 0.00
Mar 2025 73.66 0.00
Dec 2024 73.66 0.00
Sep 2024 73.66 0.00
Jun 2024 73.66 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 9.5114.
  • The company has an efficient Cash Conversion Cycle of -4.68609999999998 days.
  • Company has a healthy liquidity position with current ratio of 2.6585.
  • The company has a good cash flow management; CFO/PAT stands at 1.20638132429448.
  • The company has a high promoter holding of 73.66%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 9.05994433575933.

 Limitations

  • The company has shown a poor profit growth of -4.06545075526691% for the Past 3 years.
  • The company has shown a poor revenue growth of 9.0426090819955% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 16.68 18.19 19.57 20.66 18.14
Total Expenditure 15.07 16.88 17.6 18.54 15.78
Operating Profit 1.61 1.31 1.98 2.12 2.35
Other Income 0.15 0.21 0.53 0.18 0.18
Interest 0.14 0.15 0.13 0.13 0.15
Depreciation 0.7 0.71 0.74 0.73 0.84
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.92 0.65 1.64 1.45 1.55
Tax 0.58 0.15 0.45 0.34 0.58
Profit After Tax 0.34 0.5 1.19 1.11 0.97
Adjusted EPS (Rs) 2.85 4.18 9.93 9.25 8.06

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 68.6 57.92 75.33 75.56 75.1
Total Expenditure 59.01 50.93 66.76 66.53 68.08
Operating Profit 9.59 6.99 8.57 9.03 7.02
Other Income 0.88 0.82 1.72 1.09 1.07
Interest 0.64 0.45 0.36 0.38 0.55
Depreciation 1.92 2.45 2.48 2.82 2.88
Exceptional Items 0 0.13 0 0 0
Profit Before Tax 7.91 5.03 7.44 6.92 4.66
Tax 2.57 1.47 1.87 1.27 1.52
Net Profit 5.34 3.56 5.58 5.65 3.14
Adjusted EPS (Rs.) 44.48 29.68 46.49 47.12 26.21

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 1.2 1.2 1.2 1.2 1.2
Total Reserves 35.69 39.11 44.43 49.64 52.37
Borrowings 6.24 2.49 2.42 2.86 3.04
Other N/C liabilities 3.4 3.89 1.94 1.62 2.55
Current liabilities 18.83 15.75 14.18 12.63 15.08
Total Liabilities 65.37 62.43 64.16 67.96 74.24
Assets
Net Block 26.36 25.82 24.26 24.03 24.64
Capital WIP 0 0 0.13 3.82 9.32
Intangible WIP 0 0 0 0 0
Investments 0.01 0.01 0.01 0.01 0.01
Loans & Advances 0 0 0 0 0
Other N/C Assets 1.21 1.39 0.31 0.27 0.19
Current Assets 37.8 35.22 39.46 39.84 40.08
Total Assets 65.37 62.43 64.16 67.96 74.24
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 7.91 5.03 7.44 6.92 4.66
Adjustment 2.56 2.88 2.85 3.2 3.48
Changes in Assets & Liabilities -0.89 -0.8 -6.73 -0.64 -1.75
Tax Paid -1.37 -1.91 -1.1 -1.26 -2.39
Operating Cash Flow 8.21 5.19 2.45 8.23 4
Investing Cash Flow -4.62 -1.89 -1.06 -6.27 -9.04
Financing Cash Flow -1.24 -1.23 -1.01 -1.04 -0.99
Net Cash Flow 2.36 2.07 0.38 0.91 -6.03

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 73.66 73.66 73.66 73.66 73.66
adit dilipbhai shah 1.29 1.29 1.29 1.29 1.29
bimal ramanlal shah 1.17 1.17 1.17 1.17 1.17
dilip ramanlal shah 7.07 - 7.07 7.07 7.07
janki rajendra shah 8.67 - 8.67 8.67 8.67
kaumudini rajendra shah... 1.76 - 1.76 1.76 1.76
kishoriben dilip shah 0.28 - 0.28 0.28 0.28
paresh ramanlal shah 1.97 1.97 1.97 1.97 1.97
parulben kiranbhai laliwa... 1.02 1.02 1.02 1.02 1.02
rajendra ramanlal shah 7.14 - 7.14 7.14 7.14
shah dilip ramanlal huf... 25.88 25.88 25.88 25.88 25.88
shah rajendra ramanlal ... 17.42 - 17.42 - 17.42
shah rajendra ramanlal ... - - - 17.42 -
dilip ramanlal shah - 7.07 - - -
janki rajendra shah - 8.67 - - -
kaumudini rajendra shah - 1.76 - - -
kishoriben dilip shah - 0.28 - - -
rajendra ramanlal shah - 7.14 - - -
shah rajendra ramanlal hu... - 17.42 - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 26.34 26.34 26.34 26.34 26.34
bharati bharat dattani 1.64 1.64 1.64 1.64 1.64
investor education and pr... - 6.01 6.29 6.29 6.29
ketan babulal shah 1.23 1.23 1.23 1.23 1.23
rajeshri ketan shah - - - 2.20 2.20
sharad kanayalal shah 1.11 1.11 1.11 1.11 1.11
rajeshri k shah 2.20 2.20 2.20 - -
investor education and pr... 6.01 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Mercury Laboratories - Quaterly Results 13 Aug, 10:32 AM Mercury Laboratories - Quaterly Results 13 Aug, 10:32 AM Mercury Laboratories - Quaterly Results 13 Aug, 10:32 AM Mercury Laboratories informs about press release 19 Jul, 12:17 PM Mercury Laboratories informs about compliances certificate 7 Jul, 1:29 PM Mercury Laboratories informs about annual secretarial compliance report 17 May, 2:48 PM Mercury Laboratories - Quaterly Results 14 May, 2:43 PM Mercury Laboratories - Quaterly Results 14 May, 2:43 PM Mercury Laboratories - Quaterly Results 14 May, 2:43 PM Mercury Laboratories informs about board meeting 8 May, 5:30 PM Mercury Laboratories informs about board meeting 8 May, 12:02 PM Mercury Laboratories informs about compliances certificate 5 Apr, 2:57 PM Mercury Laboratories informs about newspaper cuttings 14 Feb, 12:03 PM Mercury Laboratories - Quaterly Results 12 Feb, 7:10 PM Mercury Laboratories - Quaterly Results 12 Feb, 7:10 PM Mercury Laboratories informs about newspaper cuttings 16 Nov, 3:38 PM Mercury Laboratories informs about compliances-certificate 7 Oct, 5:05 PM Mercury Laboratories informs about loss of share certificates 13 Sep, 12:33 PM Mercury Laboratories informs about newspaper publication 3 Sep, 5:06 PM Mercury Laboratories - Quaterly Results 24 Jul, 1:46 PM Mercury Laboratories - Quaterly Results 24 Jul, 1:46 PM Mercury Laboratories - Quaterly Results 24 Jul, 1:46 PM Mercury Laboratories informs about compliance certificate 5 Jul, 5:24 PM Mercury Laboratories informs about disclosure 21 Jun, 5:14 PM Mercury Laboratories informs about change in management 14 Jun, 12:14 PM Mercury Laboratories informs about issuance of duplicate share certificate 12 Jun, 12:50 PM Mercury Laboratories informs about details of loss of certificate 5 Jun, 5:34 PM Mercury Laboratories - Quaterly Results 28 May, 4:15 PM Mercury Laboratories - Quaterly Results 28 May, 4:15 PM Mercury Laboratories - Quaterly Results 28 May, 4:15 PM Mercury Laboratories - Quaterly Results 12 Feb, 2:33 PM Mercury Laboratories - Quaterly Results 12 Feb, 2:33 PM Mercury Laboratories - Quaterly Results 12 Feb, 2:33 PM Mercury Laboratories informs about loss of share certificates 11 Jan, 11:09 AM Mercury Laboratories informs about compliances-certificate 6 Jan, 12:31 PM Mercury Laboratories informs about closure of trading window 26 Sep, 10:53 AM Mercury Laboratories informs about loss of share certificate 20 Sep, 2:28 PM Mercury Laboratories informs about newspaper cuttings 2 Sep, 3:33 PM Mercury Laboratories - Quaterly Results 5 Aug, 9:16 PM Mercury Laboratories informs about loss of share certificate 4 Jul, 10:50 AM Mercury Laboratories informs about issue of duplicate share certificate 26 May, 1:11 PM Mercury Laboratories informs about newspaper cuttings 8 May, 12:43 PM Mercury Laboratories - Quaterly Results 5 May, 5:24 PM Mercury Laboratories - Quaterly Results 5 May, 5:24 PM Mercury Laboratories - Quaterly Results 5 May, 5:24 PM Mercury Laboratories informs about certificate 6 Apr, 12:37 PM Mercury Laboratories informs about issue of duplicate certificate 21 Mar, 2:38 PM Mercury Laboratories informs about loss of share certificate 1 Nov, 4:43 PM Mercury Laboratories informs about scrutinizer's report 28 Sep, 5:12 PM Mercury Laboratories informs about closure of trading window 27 Sep, 5:14 PM

Mercury Laboratories Stock Price Analysis and Quick Research Report. Is Mercury Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Mercury Laboratories. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Mercury Laboratories has a PE ratio of 26.8965231867128 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Mercury Laboratories has ROA of 4.4234% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Mercury Laboratories has a Current ratio of 2.6585.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Mercury Laboratories has a ROE of 6.0243%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Mercury Laboratories has a Debt to Equity ratio of 0.0764 which means that the company has low proportion of debt in its capital.

  • Sales growth: Mercury Laboratories has reported revenue growth of -0.6059% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Mercury Laboratories for the current financial year is 9.34272688052921%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Mercury Laboratories is Rs 3.5 and the yield is 0.4142%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Mercury Laboratories is Rs 31.4167. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Mercury Laboratories in Ticker for free. Also, one can get the intrinsic value of Mercury Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Mercury Laboratories FAQs

Q1. What is Mercury Laboratories share price today?
Ans: The current share price of Mercury Laboratories is Rs 845.

Q2. What is the market capitalisation of Mercury Laboratories?
Ans: Mercury Laboratories has a market capitalisation of Rs 101.4 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Mercury Laboratories?
Ans: The PE ratio of Mercury Laboratories is 26.8965231867128 and the P/B ratio of Mercury Laboratories is 1.85931560022998, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Mercury Laboratories share?
Ans: The 52-week high share price of Mercury Laboratories is Rs 1190, and the 52-week low share price of Mercury Laboratories is Rs 736.

Q5. Does Mercury Laboratories pay dividends?
Ans: Currently, Mercury Laboratories pays dividends. Dividend yield of Mercury Laboratories is around 0.4142%.

Q6. What are the face value and book value of Mercury Laboratories shares?
Ans: The face value of Mercury Laboratories shares is Rs 10, while the book value per share of Mercury Laboratories is around Rs 454.4683. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Mercury Laboratories?
Ans: Mercury Laboratories has a total debt of Rs 4.0936 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Mercury Laboratories?
Ans: The ROE of Mercury Laboratories is 6.0243% and ROCE of Mercury Laboratories is 9.1395%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Mercury Laboratories a good buy for the long term?
Ans: The Mercury Laboratories long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Mercury Laboratories undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Mercury Laboratories appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Mercury Laboratories’s financials?
Ans: You can review Mercury Laboratories’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Mercury Laboratories
X